Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. - Wikidata - wikimedia - TriplyDB

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

http://www.wikidata.org/entity/Q37395149

about

Anti-HIV-1 nanotherapeutics: promises and challenges for the future Involvement of long noncoding RNAs in diseases affecting the central nervous system Nanostructures: a platform for brain repair and augmentation Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous System Synthetic Nanoparticles for Vaccines and Immunotherapy Cell delivery of therapeutic nanoparticles Activation of latent HIV using drug-loaded nanoparticles Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Nanotechnology and HIV: potential applications for treatment and prevention.Progress in antiretroviral drug delivery using nanotechnology Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals HIV-1 neuroimmunity in the era of antiretroviral therapy.HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Co-opting biology to deliver drugs Towards nanomedicines for neuroAIDS.Optimal structural design of mannosylated nanocarriers for macrophage targeting.Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring.Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages.Cell-mediated drug delivery.Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies Natural antisense transcripts as therapeutic targets Translational challenges in targeting latent HIV infection and the CNS reservoir problem.Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes.Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.

P2860

Q26828464-5C7D211A-28D3-46A3-AB45-14671EA79C2B Q26852160-57098BA0-084D-4A72-8953-D933245C0068 Q27010023-DD113FF2-F946-4EA6-BD66-426259EE6D0B Q27312829-2E5633FD-A222-4D9A-B01F-C43D175662C5 Q28085375-46EA4604-4E60-4D5B-B8BC-5DA35A614F68 Q28385606-972C9D0D-0912-4927-94FE-D37838A2700F Q28477657-03822A4E-0A18-4C56-9AD9-ACA821747663 Q28551873-68C7C289-E98B-4750-95C3-030EB261423E Q30387307-506F0C0E-3D26-4FDD-A0E5-0DA95D2FF66F Q30393980-1760607A-AF98-4F1C-91E7-F876A7517B98 Q30395011-D25268C5-4673-429D-8FE6-7919BE0D5565 Q30401659-E79B4205-1D00-490C-A1C8-9F33B59961BC Q30469832-BBD82AE6-77A6-4BE9-88E6-79055D570AC9 Q30493643-852BCF70-C275-414E-A8FB-FF18D709B71B Q30603781-8ADD25D3-FE15-4636-95BD-0A984B6FC87C Q33614467-877289A7-02B6-4E36-A25C-F8EBB5155C63 Q33733529-B91FCDCA-4AC0-4C73-9E9C-749BE6C31259 Q33805298-AEC5B5DE-7959-4462-8FC9-EF929C365281 Q33819656-02DBC527-1451-4664-B059-7A50560DF4A9 Q33831400-1415DE18-1345-4D0A-B4D6-3904A71E4605 Q33892744-C4E20154-4B7D-4028-A919-9872F408CEA5 Q34037622-388121EB-B2C0-4D24-B69A-64C5E0248EA5 Q34059457-2FA6B158-1FD7-4558-96E1-66DB11618A86 Q34079604-FC532D66-D7C7-4E17-B7AA-4F74F5FAC00D Q34424045-50480550-2D2F-43E6-9D79-EE5B3C0BB383 Q34495140-9CA6CB9B-924F-47D2-9DD4-6B8BB28E5B5F Q34623115-5C7726EF-7651-476D-BD1D-41A5A6989946 Q34632979-559DB4F7-168B-41D0-B595-169BC86C23D6 Q34639915-FB8CC3D6-43D2-484F-A298-7296AFFA6106 Q34639923-590CB40F-BAAB-451F-87D7-3102E6F20E5E Q34641722-CDB193E9-A5E8-4BDE-9431-5C3753841582 Q34709440-73D00E52-E80C-4918-8C52-96C512AFC5D3 Q34728884-13CA2866-53F6-4B6F-AEFA-001A31236C2B Q34797004-BBF59372-A1BE-49C9-BF43-8222A3C943B2 Q34859292-0E115F57-7440-4A02-A972-AA79DAFCB57B Q35009744-3BE29591-1143-48D0-A6E0-37FB679CDB6D Q35016131-4A3E8F05-0D48-4205-853C-0D0CFFEC063C Q35071617-23187434-D9CF-4F65-BCC4-86A2C70DA994 Q35088011-A78FDA70-42EC-4EB0-943B-B9F84D77544F Q35194750-CAA3DC39-8975-4D06-82BC-2CA11579067A

P2860

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

http://www.wikidata.org/entity/Q37395149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@en

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@nl

type

label

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@en

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@nl

prefLabel

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@en

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@nl

P1433

Q37395149-157F675C-0BDE-4748-B81B-EDE5AEFC07E9

P1476

Q37395149-B0BF1A16-17FD-46BC-9CF6-993B7EDE2446

P2093

Q37395149-28BF707C-8321-4414-8DF4-2C60A3B97CF7

Q37395149-5D18478B-9910-428A-AA14-34CF87E83BB2

Q37395149-72F95873-A01C-4DFF-876D-F6E83B69C52E

Q37395149-920E09D5-653A-48EE-884A-002FA28B53CE

Q37395149-9E63B764-822F-4773-B5B5-7B4F7D628FBD

Q37395149-A15202C0-F3EC-4757-B538-6131DBE60726

Q37395149-E891E5FF-73D1-41E4-A853-C16C80C4ABE7

Q37395149-F659E02B-ACFC-4082-93FA-DAD50E243A89

P2860

Q37395149-0192853A-7AB6-4111-AB7E-F06273D202D0

Q37395149-022D6BD6-2EEF-4A4D-AEA4-B5C2A582CF05

Q37395149-04412BDD-868D-47B1-AEF3-17B709611582

Q37395149-088A41E7-0610-4949-A0CE-220A38510AA7

Q37395149-1220ED9E-5D65-4BB6-9EA8-5F492D6A464C

Q37395149-13683996-1AB7-4222-B7C9-2AEB227C7949

Q37395149-15490076-F6C0-44FD-84B5-AE89D3293FFC

Q37395149-1F34C41B-CB7D-40B4-A369-44F4E633D434

Q37395149-2D4CE69C-C99D-4653-A907-FF9D232B36FD

Q37395149-2EA9F908-7B94-4C6C-89C7-F65C076339DD

P304

Q37395149-383E2550-C9D1-4771-9288-4E4D088D317E

P31

Q37395149-E1503200-0904-40A9-B554-59B1943639D3

P356

Q37395149-EBC7988C-6099-4716-A3C6-66F107A8E7B5

P407

Q37395149-70B97665-AEE1-4561-94F9-9EC9F45F182C

P433

Q37395149-598268AD-242F-4178-97D7-C1D10720A0B4

P478

Q37395149-FD3E4846-C26D-4BA3-8C7F-1C2D80A5CA50

P50

Q37395149-0C774D61-D2A5-4E3C-AD11-ECB837151D36

P577

Q37395149-BCDBAB6F-180E-4824-AA2D-4E71FFF38966

P5875

Q37395149-D3B60446-47C9-4AB2-9E7B-7EC605F2A9F3

P698

Q37395149-4F2F06AE-EA9D-4178-AD89-A57B774CD108

P921

Q37395149-09F157D8-1C68-41EC-A547-023A4F8406EE

Q37395149-C4705C7E-4CC3-480C-8941-25B197C95DBE

Q37395149-E1A08F52-BC94-4B81-9270-D24C84FFB427

P932

Q37395149-B7AC93C4-C5E4-4A12-9777-7723E1F9A006

P356

JIMMUNOL.0900274

P1433

Journal of Immunology

P1476

Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.

@en

P2093

Barrett Rabinow

http://www.w3.org/2001/XMLSchema#string

Cassi B Grotepas

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Huanyu Dou

http://www.w3.org/2001/XMLSchema#string

James Kipp

http://www.w3.org/2001/XMLSchema#string

Jane Werling

http://www.w3.org/2001/XMLSchema#string

JoEllyn M McMillan

http://www.w3.org/2001/XMLSchema#string

Mahesh Chaubal

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

The blood brain barrier in HIV infection.

[Lesions of the central nervous system in the early stages of human immunodeficiency virus infection]

Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.

An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.

Nanotechnology-based drug delivery for cancer.

HIV-1-induced neuronal injury in the developing brain.

Antiretroviral therapy (ART) from a neurological point of view. German Neuro-AIDS study group (DNAA).

P304

661-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0900274

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Destache

P577

2009-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26300625

http://www.w3.org/2001/XMLSchema#string

P698

19535632

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2765254

http://www.w3.org/2001/XMLSchema#string